Neoinsight

Your way to successful recruitment

Next section

ABOUT US / Company Overview

Revolutionizing Cancer Research Through Clinical Trials

Our mission is to accelerate the clinical trial process by providing access to a large database of patients with various oncological diagnoses.

Thanks to our solutions, trial sponsors can achieve their patient randomization goals more quickly.

ABOUT US / Company Overview

Our company was founded in response to the growing demand in the field of clinical research.

The doctors who founded the company are well aware of the challenges associated with this process, as they have been involved in clinical research centers for many years.

On one hand, we collaborate with clinical trial sponsors, but we are equally committed to oncology patients, for whom we seek the best possible treatment options.

ABOUT US / Company Overview

We have a comprehensive patient database that includes individuals with various types of cancer.

By collaborating with physicians outside of referral centers, we can reach a wide range of patients across Poland.

Our approach to patient recruitment is decentralized, allowing patients to submit biological material at one of over 1,000 diagnostic points throughout the country.

HOW WE WORK (Clinical Trial Process)

Our clinical trial process is designed to be simple and efficient, ensuring both patients and sponsors benefit from our expertise

      Trial Enrollment
      ‍      Patients who meet the criteria are offered participation in clinical trials.

      Genetic Testing‍

      Detailed laboratory tests (NGS, PCR, FISH) identify the genetic causes of the disease, matching patients to the most suitable trials.

      Consultation

      ‍Each patient receives a teleconsultation with our Medical Council, providing personalized therapeutic recommendations.

      ‍

      Sample Collection

      ‍Blood or tissue samples are collected at one of our 1000+ diagnostic points or through home visits.

      Referral

      ‍Patients are referred by physicians or selected from our registry.

Our Impact / Success Stories

We are proud of the tangible impact our services have made in advancing cancer research:

      400+ patients matched with personalized treatments through clinical trials by 2025.

      20+ completed clinical trials in hematological malignancies and solid tumors.

      Decentralized trial management with over 1000 diagnostic points ensuring patient access from all regions of Poland. We help sponsors achieve faster randomization and recruitment goals, driving real results in the development of new treatments.

Our Services

We provide a full range of clinical trial services.

  • Patient Recruitment

    ‍We connect eligible patients to trials through our extensive network and genetic profiling.

  • Genetic Testing

    ‍Using cutting-edge technologies such as NGS, PCR, and FISH, we ensure precise identification of patients with the right genetic profiles.

  • Trial Management

    ‍From start to finish, we handle all aspects of clinical trial organization, ensuring smooth execution and adherence to regulatory standards.

  • Decentralized Diagnostics

    ‍With over 1000 diagnostic points, we offer decentralized sample collection to make trials accessible to all patients. Our focus is on providing efficient, reliable services that enhance the speed and success of clinical trials.

Certifications and Compliance

Our clinical trial operations comply with the highest standards of quality and regulatory approvals, including

Certifications and Compliance

  • FDA-approved treatments and participation in leading-edge research projects.
  • Collaborations with diagnostic networks that ensure real-world implementation of decentralized trial models. We maintain full compliance with industry regulations, offering sponsors and patients the confidence that their trials are in expert hands.
  • We are building a free, publicly available Register for patients entering our database.
  • We catalog according to histopathological diagnoses, mutation data (results of genetic tests), and received lines of treatment.

Certifications and Compliance

  • Formal cooperation with diagnostic networks allows for real implementation of the decentralization desired on the market, shortening the patient's path from home to the laboratory.
  • We have a database of referring doctors, which significantly increases the chances of success of the projects we undertake.
  • Each pre-selected patient receives a free consultation with a doctor, who reviews the patient's existing medical documentation, verifying all inclusion and exclusion criteria for a specific clinical trial.
  • This process ensures that we send patients to the screening who are most suitable for the clinical trial.
  • We facilitate contact with the patient before they arrive at the clinic.

Meet the Team / Expertise

Behind every successful trial is a dedicated team of experts. Our team includes

  • MD, PhD Michał Kwiatek

    CEO of Neoinsight, a specialist in hematologic diseases, involved in the treatment of blood cancers through clinical trials

  • Patrycja Swadźba

    COO of Neoinsight, overseeing day-to-day operations, optimizing business processes and driving strategic growth initiatives to ensure the company’s long-term success.

  • MD, PhD Łukasz Pruchniewski

    hematologist, clinical trial investigator

  • Profesor, Dr. Habil. In Medicine Wojciech Jurczak

    A leading expert in the treatment of lymphatic system cancers

  • Anna Piotrowska-Mietelska

    Expert in genetics and molecular diagnostics

Our Partners / Trusted By

We are proud to collaborate with top pharmaceutical companies, research institutions, and healthcare providers in the field of cancer research.

Our partners trust us to deliver accurate, timely, and successful clinical trials, enhancing the development of new treatments.

Reach out to us today.

Have questions?

Start a partnership

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Follow us on LinkedIn for the latest updates on our clinical trials and research projects.